EB-ResNet is a network of EB patient organisations funding EB research and partnering to drive its translation to clinical benefit. Our ambition is that scientists, clinicians, patients, and industry work closely together to achieve our overall objective: finding a cure and therapies for people living with Epidermolysis Bullosa. EB-ResNet manages the funding of promising EB research projects worldwide on behalf of its members.
We are now inviting research proposals for the ‘All-Priorities‘ Research Call. There is a one-stage application process with a submission deadline by April 06, 2020, at 15:00 GMT.
The “All-Priorities” Research Project grants scheme calls for research proposals across our four priority research areas:
- Improving understanding of EB biology to create new concepts for diagnosis and treatment.
- Developing disease-modifying and curative therapies.
- Preventing and curing severe disease consequences: chronic wounds, fibrosis, and cancer.
- Improving clinical-care and symptom-relief through research.
We offer to fund individual research projects up to €270.000 over three years.